These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21367982)

  • 1. Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.
    Porwancher RB; Hagerty CG; Fan J; Landsberg L; Johnson BJ; Kopnitsky M; Steere AC; Kulas K; Wong SJ
    Clin Vaccine Immunol; 2011 May; 18(5):851-9. PubMed ID: 21367982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
    Porwancher R; Landsberg L
    PLoS One; 2021; 16(9):e0253514. PubMed ID: 34499659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
    Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
    Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
    Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
    Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of serologic tests for lyme disease.
    Steere AC; McHugh G; Damle N; Sikand VK
    Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.
    Branda JA; Aguero-Rosenfeld ME; Ferraro MJ; Johnson BJ; Wormser GP; Steere AC
    Clin Infect Dis; 2010 Jan; 50(1):20-6. PubMed ID: 19947857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
    Dickeson DJ; Chen SC; Sintchenko VG
    Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
    Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
    J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
    Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.
    Lahey LJ; Panas MW; Mao R; Delanoy M; Flanagan JJ; Binder SR; Rebman AW; Montoya JG; Soloski MJ; Steere AC; Dattwyler RJ; Arnaboldi PM; Aucott JN; Robinson WH
    J Clin Microbiol; 2015 Dec; 53(12):3834-41. PubMed ID: 26447113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.
    Baarsma ME; Vrijlandt A; Ursinus J; Zaaijer HL; Jurriaans S; van Dam AP; Hovius JW
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):387-393. PubMed ID: 34806121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.
    Goettner G; Schulte-Spechtel U; Hillermann R; Liegl G; Wilske B; Fingerle V
    J Clin Microbiol; 2005 Aug; 43(8):3602-9. PubMed ID: 16081885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
    Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.
    Bacon RM; Biggerstaff BJ; Schriefer ME; Gilmore RD; Philipp MT; Steere AC; Wormser GP; Marques AR; Johnson BJ
    J Infect Dis; 2003 Apr; 187(8):1187-99. PubMed ID: 12695997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease.
    Landry ML; Hassan S; Rottmann BG; Pesak SJ; Ordazzo M; Skrzyniarz M; Deponte S; Peaper DR
    J Clin Microbiol; 2024 May; 62(5):e0013924. PubMed ID: 38597655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
    Peltomaa M; McHugh G; Steere AC
    Otol Neurotol; 2004 Sep; 25(5):838-41. PubMed ID: 15354020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis].
    Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I
    Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease.
    Embers ME; Hasenkampf NR; Barnes MB; Didier ES; Philipp MT; Tardo AC
    Clin Vaccine Immunol; 2016 Apr; 23(4):294-303. PubMed ID: 26843487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.